Table of Content

Table of Contents



Global Influenza Vaccine Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

1 Market Scope

1.1 Product Details and Introduction

1.1.1 Trivalent Influenza Vaccine -Product Introduction and Major Manufacturers

1.1.2 Quadrivalent Influenza Vaccine -Product Introduction and Major Manufacturers

1.1.3 Other -Product Introduction and Major Manufacturers

1.2 Market Snapshot

1.2.1 Major Companies Overview

1.2.2 Market Concentration

1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

2 Regional Market

2.1 Regional Market Share in Terms of Production (2019-2026)

2.2 Regional Market Share in Terms of Revenue (2019-2026)

2.3 Regional Market Share in Terms of Consumption (2019-2026)

3 Global Influenza Vaccine Market Assessment by Type

3.1 Global Influenza Vaccine Production by Type (2015-2026)

3.2 Global Influenza Vaccine Revenue by Type (2015-2026)

3.3 North America Influenza Vaccine Production and Revenue by Type (2015-2026)

3.4 Asia Influenza Vaccine Production and Revenue by Type (2015-2026)

3.5 Europe Influenza Vaccine Production and Revenue by Type (2015-2026)

3.6 Middle East & Africa Influenza Vaccine Production and Revenue by Type (2015-2026)

3.7 South America Influenza Vaccine Production and Revenue by Type (2015-2026)



4 Global Influenza Vaccine Market Assessment by Application

4.1 Historical & Forecast Global Influenza Vaccine Consumption, Different Application Field (2015-2026)

4.2 Historical & Forecast North America Influenza Vaccine Consumption, Different Application Field (2015-2026)

4.3 Historical & Forecast Asia Influenza Vaccine Consumption, Different Application Field (2015-2026)

4.4 Historical & Forecast Europe Influenza Vaccine Consumption, Different Application Field (2015-2026)

4.5 Historical & Forecast Middle East & Africa Influenza Vaccine Consumption, Different Application Field (2015-2026)

4.6 Historical & Forecast South America Influenza Vaccine Consumption, Different Application Field (2015-2026)



5 North America

5.1 US Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

5.2 Canada Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

5.3 Mexico Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6 Asia

6.1 China Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.2 Japan Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.3 India Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.4 Korea Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.5 Southeat Asia Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7 Europe

7.1 Germany Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.2 UK Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.3 France Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.4 Russia Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.5 Italy Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8 Middle East and Africa

8.1 Saudi Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.2 UAE Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.3 Egypt Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.4 Nigeria Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.5 South Africa Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

9 South America

9.1 Brazil Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

9.2 Argentina Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

9.3 Colombia Influenza Vaccine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

10 Global Influenza Vaccine Average Price Trend

10.1 Market Price for Each Type of Influenza Vaccine in North America (2015-2026)

10.2 Market Price for Each Type of Influenza Vaccine in Asia (2015-2026)

10.3 Market Price for Each Type of Influenza Vaccine in Europe (2015-2026)

10.4 Market Price for Each Type of Influenza Vaccine in Middle East & Africa (2015-2026)

10.5 Market Price for Each Type of Influenza Vaccine in South America (2015-2026)



11 Value Chain (Impact of COVID-19)

11.1 Influenza Vaccine Value Chain Analysis

11.1.1 Upstream

11.1.2 Downstream

11.2 COVID-19 Impact on Influenza Vaccine Industry

11.2.1 Industrial Policy Issued Under the Epidemic Situation

11.3 Cost-Under the Epidemic Situation

11.3.1 Cost of Raw Material

11.4 Channel Analysis

11.4.1 Distribution Channel-Under the Epidemic Situation

11.4.2 Distributors



12 Influenza Vaccine Competitive Analysis

12.1 GSK

12.1.1 GSK Company Profiles

12.1.2 GSK Product Introduction

12.1.3 GSK Influenza Vaccine Production, Revenue (2015-2020)

12.1.4 SWOT Analysis

12.2 Sinovac

12.2.1 Sinovac Company Profiles

12.2.2 Sinovac Product Introduction

12.2.3 Sinovac Influenza Vaccine Production, Revenue (2015-2020)

12.2.4 SWOT Analysis

12.3 Changsheng

12.3.1 Changsheng Company Profiles

12.3.2 Changsheng Product Introduction

12.3.3 Changsheng Influenza Vaccine Production, Revenue (2015-2020)

12.3.4 SWOT Analysis

12.4 CCBIO

12.4.1 CCBIO Company Profiles

12.4.2 CCBIO Product Introduction

12.4.3 CCBIO Influenza Vaccine Production, Revenue (2015-2020)

12.4.4 SWOT Analysis

12.5 Hualan Bio

12.5.1 Aleph Biomedical Company Profiles

12.5.2 Aleph Biomedical Product Introduction

12.5.3 Aleph Biomedical Influenza Vaccine Production, Revenue (2015-2020)

12.5.4 SWOT Analysis

12.6 Sanofi

12.6.1 Sanofi Company Profiles

12.6.2 Sanofi Product Introduction

12.6.3 Sanofi Influenza Vaccine Production, Revenue (2015-2020)

12.6.4 SWOT Analysis

12.7 Lanzhou Institute Of Biological Product

12.7.1 Lanzhou Institute Of Biological Product Company Profiles

12.7.2 Lanzhou Institute Of Biological Product Product Introduction

12.7.3 Lanzhou Institute Of Biological Product Influenza Vaccine Production, Revenue (2015-2020)

12.7.4 SWOT Analysis

12.8 Siobp

12.8.1 Siobp Company Profiles

12.8.2 Siobp Product Introduction

12.8.3 Siobp Influenza Vaccine Production, Revenue (2015-2020)

12.8.4 SWOT Analysis

12.9 Hualan Bio

12.9.1 Hualan Bio Company Profiles

12.9.2 Hualan Bio Product Introduction

12.9.3 Hualan Bio Influenza Vaccine Production, Revenue (2015-2020)

12.9.4 SWOT Analysis

12.10 Tianyuan Bio-Pharma

12.10.1 Tianyuan Bio-Pharma Company Profiles

12.10.2 Tianyuan Bio-Pharma Product Introduction

12.10.3 Tianyuan Bio-Pharma Influenza Vaccine Production, Revenue (2015-2020)

12.10.4 SWOT Analysis

12.11 Vaxtec

12.12 Hissen

12.13 Abbott

12.14 Novartis

12.15 Tasly&Jenner

12.16 Tiantan

13 Conclusion

List of Figure

List of Tables and Figures



Figure Product Introduction

Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)

Figure Global Influenza Vaccine Production Market Share of Top 5 Players

Table CAGR of Major Market (2021-2026)

Table CAGR in Terms of Production of Each Type (2015-2026)

Table Regional Market Share in Terms of Production (2019-2026)

Figure Regional Market Share in Terms of Production (2019 - 2020)

Table Regional Market Share in Terms of Revenue (2019-2026)

Figure Regional Market Share in Terms of Revenue (2019 - 2020)

Figure Regional Market Share in Terms of Consumption (2019 - 2020)

Figure Regional Market Share in Terms of Consumption (2019 - 2020)

Table Global Influenza Vaccine Production (K Unit) by Type (2015-2026)

Figure Global Influenza Vaccine Production (K Unit) and Growth Rate (2015-2026)

Figure Global Influenza Vaccine Production Market Share (%) by Type (2019 -2020)

Table Global Influenza Vaccine Revenue (Million USD) by Type (2015-2026)

Figure Global Influenza Vaccine Revenue (Million USD) and Growth Rate (2015-2026)

Figure Global Influenza Vaccine Revenue Market Share (%) by Type (2019-2020)

Figure North America Influenza Vaccine Production (K Unit) by Type (2015-2026)

Figure North America Influenza Vaccine Production (K Unit) and Growth Rate (2015-2026)

Figure North America Influenza Vaccine Revenue (Million USD) by Type (2015-2026)

Figure North America Influenza Vaccine Revenue (Million USD) and Growth Rate (2015-2026)

Figure Asia Influenza Vaccine Production (K Unit) by Type (2015-2026)

Figure Asia Influenza Vaccine Production (K Unit) and Growth Rate (2015-2026)

Figure Asia Influenza Vaccine Revenue (Million USD) by Type (2015-2026)

Figure Asia Influenza Vaccine Revenue (Million USD) and Growth Rate (2015-2026)

Figure Europe Influenza Vaccine Production (K Unit) by Type (2015-2026)

Figure Europe Influenza Vaccine Production (K Unit) and Growth Rate (2015-2026)

Figure Europe Influenza Vaccine Revenue (Million USD) by Type (2015-2026)

Figure Europe Influenza Vaccine Revenue (Million USD) and Growth Rate (2015-2026)

Figure Middle East & Africa Influenza Vaccine Production (K Unit) by Type (2015-2026)

Figure Middle East & Africa Influenza Vaccine Production (K Unit) and Growth Rate (2015-2026)

Figure Middle East & Africa Influenza Vaccine Revenue (Million USD) by Type (2015-2026)

Figure Middle East & Africa Influenza Vaccine Revenue (Million USD) and Growth Rate (2015-2026)

Figure South America Influenza Vaccine Production (K Unit) by Type (2015-2026)

Figure South America Influenza Vaccine Production (K Unit) and Growth Rate (2015-2026)

Figure South America Influenza Vaccine Revenue (Million USD) by Type (2015-2026)

Figure South America Influenza Vaccine Revenue (Million USD) and Growth Rate (2015-2026)

Table Historical & Forecast Influenza Vaccine Different Application Field Consumption (K Unit)

Figure Consumption (K Unit) and Growth Rate (2015-2026)

Figure Different Application Field Consumption Market Share (%) (2019-2020)

Table Historical & Forecast Influenza Vaccine Different Application Field Consumption (K Unit)

Figure North America Influenza Vaccine Consumption (K Unit) and Growth Rate (2015-2026)

Figure North America Influenza Vaccine Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Influenza Vaccine Different Application Field Consumption (K Unit)

Figure Asia Influenza Vaccine Consumption (K Unit) and Growth Rate (2015-2026)

Figure Asia Influenza Vaccine Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Influenza Vaccine Different Application Field Consumption (K Unit)

Figure Europe Influenza Vaccine Consumption (K Unit) and Growth Rate (2015-2026)

Figure Europe Influenza Vaccine Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Influenza Vaccine Different Application Field Consumption (K Unit)

Figure Middle East & Africa Influenza Vaccine Consumption (K Unit) and Growth Rate (2015-2026)

Figure Middle East & Africa Influenza Vaccine Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Influenza Vaccine Different Application Field Consumption (K Unit)

Figure South America Influenza Vaccine Consumption (K Unit) and Growth Rate (2015-2026)

Figure South America Influenza Vaccine Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Influenza Vaccine Different Application Field Consumption (K Unit)

Table US Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Canada Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Mexico Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table China Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Japan Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table India Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Korea Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Southeast Asia Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Germany Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table UK Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table France Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Russia Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Italy Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Saudi Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table UAE Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Egypt Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Nigeria Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table South Africa Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Brazil Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Argentina Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Colombia Influenza Vaccine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Market Price (USD/Unit) for Each Type of Influenza Vaccine in China

Table Market Price (USD/Unit) for Each Type of Influenza Vaccine in EU

Table Market Price (USD/Unit) for Each Type of Influenza Vaccine in USA

Table Market Price (USD/Unit) for Each Type of Influenza Vaccine in Japan

Table Market Price (USD/Unit) for Each Type of Influenza Vaccine in India

Table Market Price (USD/Unit) for Each Type of Influenza Vaccine in Southeast Asia

Table Market Price (USD/Unit) for Each Type of Influenza Vaccine in South America

Figure Value Chain Structure of Influenza Vaccine

Table Value Chain

Table Key Suppliers of Raw Material/Components

Table Key Downstream Customer in Each Application Field

Table Industry News List of Influenza Vaccine

Figure Cost Structure of Influenza Vaccine in 2020

Table Distributors/Traders List

Table GSK Profiles

Table GSK Influenza Vaccine Product Introduction

Figure GSK Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure GSK SWOT Analysis

Table Sinovac Profiles

Table Sinovac Influenza Vaccine Product Introduction

Figure Sinovac Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Sinovac SWOT Analysis

Table Changsheng Profiles

Table Changsheng Influenza Vaccine Product Introduction

Figure Changsheng Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Changsheng SWOT Analysis

Table CCBIO Profiles

Table CCBIO Influenza Vaccine Product Introduction

Figure CCBIO Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure CCBIO SWOT Analysis

Table Aleph Biomedical Profiles

Table Aleph Biomedical Influenza Vaccine Product Introduction

Figure Aleph Biomedical Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Aleph Biomedical SWOT Analysis

Table Sanofi Profiles

Table Sanofi Influenza Vaccine Product Introduction

Figure Sanofi Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Sanofi SWOT Analysis

Table Lanzhou Institute Of Biological Product Profiles

Table Lanzhou Institute Of Biological Product Influenza Vaccine Product Introduction

Figure Lanzhou Institute Of Biological Product Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Lanzhou Institute Of Biological Product SWOT Analysis

Table Siobp Profiles

Table Siobp Influenza Vaccine Product Introduction

Figure Siobp Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Siobp SWOT Analysis

Table Hualan Bio Profiles

Table Hualan Bio Influenza Vaccine Product Introduction

Figure Hualan Bio Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Hualan Bio SWOT Analysis

Table Tianyuan Bio-Pharma Profiles

Table Tianyuan Bio-Pharma Influenza Vaccine Product Introduction

Figure Tianyuan Bio-Pharma Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Tianyuan Bio-Pharma SWOT Analysis

Table Vaxtec Profiles

Table Vaxtec Influenza Vaccine Product Introduction

Figure Vaxtec Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Vaxtec SWOT Analysis

Table Hissen Profiles

Table Hissen Influenza Vaccine Product Introduction

Figure Hissen Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Hissen SWOT Analysis

Table Abbott Profiles

Table Abbott Influenza Vaccine Product Introduction

Figure Abbott Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Abbott SWOT Analysis

Table Novartis Profiles

Table Novartis Influenza Vaccine Product Introduction

Figure Novartis Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Novartis SWOT Analysis

Table Tasly&Jenner Profiles

Table Tasly&Jenner Influenza Vaccine Product Introduction

Figure Tasly&Jenner Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Tasly&Jenner SWOT Analysis

Table Tiantan Profiles

Table Tiantan Influenza Vaccine Product Introduction

Figure Tiantan Influenza Vaccine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)